Vaccines
Stories
-
Sanofi posts results of Phase 3 MenACYW conjugate vaccine study in infants
Sanofi Pasteur posted results of a Phase 3 study that compared MenACYW conjugate vaccine with Nimenrix in 840 infants on 2026-10-07. The record lists geometric mean titers and seroresponse for serogroups A, C, W and Y.